Oxidative stress and neurodegenerative diseases: a bidirectional Mendelian randomization study

Reference

• Li D, Liu C. Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases. Nat Rev Neurosci. 2022;23:523–34. doi:10.1038/s41583-022-00603-7
   PubMed Web of Science ®Google Scholar
• Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. 2021;27:954–963.
   PubMed Web of Science ®Google Scholar
• Rabbito A, Dulewicz M, Kulczyńska-Przybik A, Mroczko B. Biochemical markers in Alzheimer's disease. Int J Mol Sci. 2020;21:1989. doi:10.3390/ijms21061989
   PubMed Web of Science ®Google Scholar
• Gaugler J, James B, Johnson T, Reimer J, Solis M, Weuve J, et al. 2022 Alzheimer's disease facts and figures. Alzheimers Dement. 2022;18:700–89. doi:10.1002/alz.12638
   PubMed Web of Science ®Google Scholar
• Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut P, Feyder M, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Prog Neurobiol. 2015;132:96–168. doi:10.1016/j.pneurobio.2015.07.002
   PubMed Web of Science ®Google Scholar
• Melo A, Monteiro L, Lima RM, Oliveira DM, Cerqueira MD, El-Bachá RS. Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxid Med Cell Longev. 2011;2011:467180. doi:10.1155/2011/467180
   PubMed Web of Science ®Google Scholar
• Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2020;267:944–53. doi:10.1007/s00415-019-09652-y
   PubMed Web of Science ®Google Scholar
• Xu L, Chen L, Wang S, Feng J, Liu L, Liu G, et al. Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study. J Neurol Neurosurg Psychiatry. 2020;91:520–5. doi:10.1136/jnnp-2019-322317
   PubMed Web of Science ®Google Scholar
• Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med. 2013;62:90–101. doi:10.1016/j.freeradbiomed.2012.11.014
   PubMed Web of Science ®Google Scholar
• Baltazar MT, Dinis-Oliveira RJ, de Lourdes BM, Tsatsakis AM, Duarte JA, Carvalho F. Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases – a mechanistic approach. Toxicol Lett. 2014;230:85–103. doi:10.1016/j.toxlet.2014.01.039
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787–95. doi:10.1038/nature05292
   PubMed Web of Science ®Google Scholar
• Wu Z, Malihi Z, Stewart AW, Lawes CM, Scragg R. The association between vitamin D concentration and pain: a systematic review and meta-analysis. Public Health Nutr. 2018;21:2022–37. doi:10.1017/S1368980018000551
   PubMed Web of Science ®Google Scholar
• Wu Z, Malihi Z, Stewart AW, Lawes CM, Scragg R. Effect of vitamin D supplementation on pain: a systematic review and meta-analysis. Pain Physician. 2016;19:415–27.
   PubMed Web of Science ®Google Scholar
• Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, et al. Oxidative stress in neurodegenerative diseases. Mol Neurobiol. 2016;53:4094–125. doi:10.1007/s12035-015-9337-5
   PubMed Web of Science ®Google Scholar
• Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24:325–40. doi:10.5607/en.2015.24.4.325
   PubMed Web of Science ®Google Scholar
• Poljsak B, Šuput D, Milisav I. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxid Med Cell Longev. 2013;2013:956792. doi:10.1155/2013/956792
   PubMed Web of Science ®Google Scholar
• Lu Z, Pu C, Zhang Y, Sun Y, Liao Y, Kang Z, et al. Oxidative stress and psychiatric disorders: evidence from the bidirectional Mendelian randomization study. Antioxidants (Basel). 2022;11:1386.
   PubMedGoogle Scholar
• Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55–74. doi:10.1016/j.ejmech.2015.04.040
   PubMed Web of Science ®Google Scholar
• Zalewska A, Klimiuk A, Zięba S, Wnorowska O, Rusak M, Waszkiewicz N, et al. Salivary gland dysfunction and salivary redox imbalance in patients with Alzheimer's disease. Sci Rep. 2021;11:23904. doi:10.1038/s41598-021-03456-9
   PubMed Web of Science ®Google Scholar
• Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing. 2001;30:235–41. doi:10.1093/ageing/30.3.235
   PubMed Web of Science ®Google Scholar
• Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett. 2010;469:6–10. doi:10.1016/j.neulet.2009.11.033
   PubMed Web of Science ®Google Scholar
• Schrag M, Mueller C, Zabel M, Crofton A, Kirsch WM, Ghribi O, et al. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiol Dis. 2013;59:100–10. doi:10.1016/j.nbd.2013.07.005
   PubMed Web of Science ®Google Scholar
• Foy CJ, Passmore AP, Vahidassr MD, Young IS, Lawson JT. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. Qjm. 1999;92:39–45. doi:10.1093/qjmed/92.1.39
   PubMed Web of Science ®Google Scholar
• Koppula S, Kumar H, More SV, Kim BW, Kim IS, Choi DK. Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease. Int J Mol Sci. 2012;13:10608–29. doi:10.3390/ijms130810608
   PubMed Web of Science ®Google Scholar
• Nikam S, Nikam P, Ahaley SK, Sontakke AV. Oxidative stress in Parkinson's disease. Indian J Clin Biochem. 2009;24:98–101. doi:10.1007/s12291-009-0017-y
   PubMedGoogle Scholar
• Cova E, Bongioanni P, Cereda C, Metelli MR, Salvaneschi L, Bernuzzi S, et al. Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients. Neurochem Int. 2010;56:687–93. doi:10.1016/j.neuint.2010.02.004
   PubMed Web of Science ®Google Scholar
• Golenia A, Leśkiewicz M, Regulska M, Budziszewska B, Szczęsny E, Jagiełła J, et al. Catalase activity in blood fractions of patients with sporadic ALS. Pharmacol Rep. 2014;66:704–7. doi:10.1016/j.pharep.2014.02.021
   PubMed Web of Science ®Google Scholar
• Babu GN, Kumar A, Chandra R, Puri SK, Singh RL, Kalita J, et al. Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease. Neurochem Int. 2008;52:1284–9. doi:10.1016/j.neuint.2008.01.009
   PubMed Web of Science ®Google Scholar
• Kuźma M, Jamrozik Z, Barańczyk-Kuźma A. Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis. Clin Chim Acta. 2006;364:217–21. doi:10.1016/j.cccn.2005.07.008
   PubMed Web of Science ®Google Scholar
• Thonhoff JR, Berry JD, Macklin EA, Beers DR, Mendoza PA, Zhao W, et al. Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022;9:e200019. doi:10.1212/NXI.0000000000200019
   PubMed Web of Science ®Google Scholar
• Yang A, Wu J, Chen Y, Shen R, Kou X. Study on multi-target synergistic treatment of Alzheimer's disease based on metal chelators. Curr Drug Targets. 2023;24:131–150.
   PubMed Web of Science ®Google Scholar
• Aaseth J, Dusek P, Roos PM. Prevention of progression in Parkinson's disease. Biometals. 2018;31:737–47. doi:10.1007/s10534-018-0131-5
   PubMed Web of Science ®Google Scholar
• Jiang T, Sun Q, Chen S. Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. Prog Neurobiol. 2016;147:1–19. doi:10.1016/j.pneurobio.2016.07.005
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhong C. Oxidative stress in Alzheimer's disease. Neurosci Bull. 2014;30:271–81. doi:10.1007/s12264-013-1423-y
   PubMed Web of Science ®Google Scholar
• Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease. Aging Cell. 2019;18:e13031. doi:10.1111/acel.13031
   PubMed Web of Science ®Google Scholar
• Cunha-Oliveira T, Montezinho L, Mendes C, Firuzi O, Saso L, Oliveira PJ, et al. Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for pharmacological intervention. Oxid Med Cell Longev. 2020;2020:5021694. doi:10.1155/2020/5021694
   PubMed Web of Science ®Google Scholar
• Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133–63. doi:10.1002/sim.3034
   PubMed Web of Science ®Google Scholar
• Skrivankova VW, Richmond RC, Woolf B, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. Jama. 2021;326:1614–21. doi:10.1001/jama.2021.18236
   PubMed Web of Science ®Google Scholar
• Skrivankova VW, Richmond RC, Woolf B, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): explanation and elaboration. Br Med J. 2021;375:n2233. doi:10.1136/bmj.n2233
   PubMedGoogle Scholar
• Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73–9. doi:10.1038/s41586-018-0175-2
   PubMed Web of Science ®Google Scholar
• Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. doi:10.7554/eLife.34408
   PubMed Web of Science ®Google Scholar
• Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46:543–50. doi:10.1038/ng.2982
   PubMed Web of Science ®Google Scholar
• Li R, Deng M, Lin Y, Gao W, Liu B, Xia H. Genetically predicted circulating levels of glycine, glutamate, and serotonin in relation to the risks of three major neurodegenerative diseases: a Mendelian randomization analysis. Front Aging Neurosci. 2022;14:938408. doi:10.3389/fnagi.2022.938408
   PubMed Web of Science ®Google Scholar
• Cui G, Li S, Ye H, Yang Y, Huang Q, Chu Y, et al. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study. Front Immunol. 2022;13:956005. doi:10.3389/fimmu.2022.956005
   PubMed Web of Science ®Google Scholar
• Cullell N, Cárcel-Márquez J, Gallego-Fábrega C, Muiño E, Llucià-Carol L, Lledós M, et al. Sleep/wake cycle alterations as a cause of neurodegenerative diseases: A Mendelian randomization study. Neurobiol Aging. 2021;106:320–1. doi:10.1016/j.neurobiolaging.2021.05.008
   Web of Science ®Google Scholar
• Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40:740–52. doi:10.1093/ije/dyq151
   PubMed Web of Science ®Google Scholar
• Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65. doi:10.1002/gepi.21758
   PubMed Web of Science ®Google Scholar
• Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladâcenco O, Roza E, et al. An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci. 2022;23:5938.
   PubMed Web of Science ®Google Scholar
• Domanskyi A, Parlato R. Oxidative stress in neurodegenerative diseases. Antioxidants (Basel). 2022;11:504.
   PubMedGoogle Scholar
• Wang H, Wu S, Wang L, Gou X, Guo X, Liu Z, et al. Association between serum total bilirubin and Alzheimer's disease: a bidirectional Mendelian randomization study. Arch Gerontol Geriatr. 2022;103:104786. doi:10.1016/j.archger.2022.104786
   PubMed Web of Science ®Google Scholar
• Cheng WW, Zhu Q, Zhang HY. Mineral nutrition and the risk of chronic diseases: a Mendelian randomization study. Nutrients. 2019;11:378.
   PubMed Web of Science ®Google Scholar
• Ashok A, Andrabi SS, Mansoor S, Kuang Y, Kwon BK, Labhasetwar V. Antioxidant therapy in oxidative stress-induced neurodegenerative diseases: role of nanoparticle-based drug delivery systems in clinical translation. Antioxidants (Basel). 2022;11:408.
   PubMedGoogle Scholar
• Kumar A, Singh A. A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions. Front Pharmacol. 2015;6:206. doi:10.3389/fphar.2015.00206
   PubMed Web of Science ®Google Scholar
• Tzounakas VL, Anastasiadi AT, Arvaniti VZ, Lelli V, Fanelli G, Paronis EC, et al. Supplementation with uric and ascorbic acid protects stored red blood cells through enhancement of non-enzymatic antioxidant activity and metabolic rewiring. Redox Biol. 2022;57:102477. doi:10.1016/j.redox.2022.102477
   PubMed Web of Science ®Google Scholar
• Elango N, Samuel S, Chinnakkannu P. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation. Clin Chim Acta. 2006;373:92–8. doi:10.1016/j.cca.2006.05.021
   PubMed Web of Science ®Google Scholar
• Gopi N, Vijayakumar S, Thaya R, Govindarajan M, Alharbi NS, Kadaikunnan S, et al. Chronic exposure of Oreochromis niloticus to sub-lethal copper concentrations: effects on growth, antioxidant, non-enzymatic antioxidant, oxidative stress and non-specific immune responses. J Trace Elem Med Biol. 2019;55:170–9. doi:10.1016/j.jtemb.2019.06.011
   PubMed Web of Science ®Google Scholar
• Sikora J, Ouagazzal AM. Synaptic zinc: an emerging player in Parkinson's disease. Int J Mol Sci. 2021;22:4724.
   PubMed Web of Science ®Google Scholar
• Anirudhan A, Angulo-Bejarano PI, Paramasivam P, Manokaran K, Kamath SM, Murugesan R, et al. RPL6: a key molecule regulating zinc- and magnesium-bound metalloproteins of Parkinson's disease. Front Neurosci. 2021;15:631892. doi:10.3389/fnins.2021.631892
   PubMed Web of Science ®Google Scholar
• Costa I, Barbosa DJ, Benfeito S, Silva V, Chavarria D, Borges F, et al. Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther. 2023;244:108373. doi:10.1016/j.pharmthera.2023.108373
   PubMed Web of Science ®Google Scholar
• Fryer MJ. Vitamin E status and neurodegenerative disease. Nutr Neurosci. 1998;1:327–51. doi:10.1080/1028415X.1998.11747243
   PubMedGoogle Scholar
• Cacabelos D, Ayala V, Granado-Serrano AB, Jové M, Torres P, Boada J, et al. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis. Neurobiol Dis. 2016;88:148–60. doi:10.1016/j.nbd.2016.01.007
   PubMed Web of Science ®Google Scholar
• Michal FD, Kuncl RW, Weinstein SJ, Malila N, Virtamo J, Albanes D. Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:246–51. doi:10.3109/21678421.2012.745570
   PubMed Web of Science ®Google Scholar
• Boccardi V, Carino S, Marinelli E, Lapenna M, Caironi G, Bianco AR, et al. Uric acid and late-onset Alzheimer's disease: results from the ReGAl 2.0 project. Aging Clin Exp Res. 2021;33:361–6. doi:10.1007/s40520-020-01541-z
   PubMed Web of Science ®Google Scholar
• Du N, Xu D, Hou X, Song X, Liu C, Chen Y, et al. Inverse association between serum uric acid levels and Alzheimer's disease risk. Mol Neurobiol. 2016;53:2594–9. doi:10.1007/s12035-015-9271-6
   PubMed Web of Science ®Google Scholar
• Qiao M, Chen C, Liang Y, Luo Y, Wu W. The influence of serum uric acid level on Alzheimer's disease: a narrative review. Biomed Res Int. 2021;2021:5525710.
   PubMed Web of Science ®Google Scholar
• Ye BS, Lee WW, Ham JH, Lee JJ, Lee PH, Sohn YH. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline? Eur J Neurol. 2016;23:948–57. doi:10.1111/ene.12969
   PubMed Web of Science ®Google Scholar
• Kim JW, Byun MS, Yi D, Lee JH, Jeon SY, Ko K, et al. Serum uric acid, Alzheimer-related brain changes, and cognitive impairment. Front Aging Neurosci. 2020;12:160. doi:10.3389/fnagi.2020.00160
   PubMed Web of Science ®Google Scholar